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Abstract
Background: Oral cancer incidence is high on the Island of Puerto Rico (PR), particularly among males. As part of a
larger study conducted in PR, we evaluated smoking and drinking as risk factors for oral potentially malignant
disorders (OPMDs).
Methods: Persons diagnosed with either an OPMD (n = 86) [oral epithelial dysplasia (OED), oral hyperkeratosis/
epithelial hyperplasia without OED] or a benign oral tissue condition (n = 155) were identified through PR
pathology laboratories. Subjects were interviewed using a standardized, structured questionnaire that obtained
information, including detailed histories of smoking and drinking. Odds ratios (ORs) for smoking and drinking in
relation to having an OPMD, relative to persons with a benign oral tissue condition, were obtained using logistic
regression and adjusted for age, gender, education, fruit/vegetable intake and smoking or drinking.
Results: For persons with an OPMD and relative to individuals with a benign oral tissue condition, the adjusted OR
for current smoking was 4.32 (95% CI: 1.99-9.38), while for former smokers, the ORadj was 1.47 (95% CI: 0.67-3.21),
each ORadj relative to never smokers. With regard to drinking, no adjusted ORs approached statistical significance,
and few point estimates exceeded 1.0, whether consumption was defined in terms of ever, current, level (drinks/
week), or beverage type.
Conclusions: In this study, conducted in Puerto Rico, current smoking was a substantial risk factor for OPMDs
while former smokers had a considerably reduced risk compared to current smokers. There was little evidence
suggesting that alcohol consumption was positively associated with OPMD risk.
Background
The clinical term “oral potentially malignant disorders”
(OPMDs) is used to refer to a number of clinical pre-
sentations that carry an elevated risk of oral cancer [1].
In Puerto Rico, OPMDs most frequently present as leu-
koplakia and erythroplakia and are often diagnosed his-
topathologically as oral hyperkeratosis, epithelial
hyperplasia, and epithelial dysplasia (OED). Oral hyper-
keratosis presents histopathologically as a thickened ker-
atotic layer on the epithelial surface, epithelial
hyperplasia is characterized by a thickening of the spi-
nous spinosum (acanthosis) and OED presents as
alterations in cellular proliferation and maturation of
the oral epithelium [1-3]. Previous reports have docu-
mented the malignant potential of oral hyperkeratosis/
epithelial hyperplasia and OED [4-9].
It is well-established that tobacco smoking and alcohol
consumption are important independent risk factors for
squamous cell carcinoma of the oral cavity and pharynx
[10,11]. A number of studies in disparate areas around
the world have also reported a positive association
between smoking tobacco and the risk of both oral leu-
koplakia and OED [12]. Findings with regard to a link
between alcohol consumption and OPMDs have been
less consistent [12].
The purpose of the current analysis was to evaluate
smoking and drinking as risk factors for OPMDs on the
island of Puerto Rico where a high incidence of oral
cancer is observed, particularly among males [13].
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All individuals diagnosed with an OPMD or a benign
oral tissue condition were identified by reviewing
pathology reports generated via pathology laboratories
located in cities around Puerto Rico. The study began
with one participating laboratory in February 2003; addi-
tional laboratories were added over time to a total of six
in October 2007 at the conclusion of subject identifica-
tion. Persons with a histopathologic diagnosis of oral
hyperkeratosis, epithelial hyperplasia, or OED were cate-
gorized as having an OPMD. Seven subjects diagnosed
with lichen planus were excluded from the primary ana-
lysis given the controversy over its malignant potential
[14], but those subjects were included as OPMD cases
in a secondary analysis. Individuals histopathologically
diagnosed with one or more of the following were clas-
sified as having a benign oral tissue condition: benign
adenoma, amalgam tattoo, cyst, fibroma, fibrous histocy-
toma, granuloma, hemangioma, incontinentia pigmenti,
inflammation, benign ulceration, lipoma, mucocele,
mucositis, papilloma, Sjoegren syndrome, sialandenitis,
or reactive, non-epithelial hyperplasia. When a subject
was diagnosed with more than one eligible oral abnorm-
ality, s/he was classified as having the more severe dis-
ease condition, e.g., if a subject was diagnosed with both
a benign oral tissue condition and OED, the disease sta-
tus was classified as OED.
Subjects were included in the study if they were 30+
years of age at diagnosis, had no previous history of the
diagnosed oral abnormality, could speak Spanish or Eng-
lish, and were able to provide reliable exposure informa-
tion as judged by the trained interviewers.
After obtaining permission to contact an identified
individual from his/her surgeon of record, each potential
subject was contacted by study personnel, first via mail,
and subsequently via telephone to answer any questions
regarding participation and to schedule an in-person
interview appointment. Two trained interviewers, who
were blinded to both study hypotheses and disease sta-
tus, used a standardized, structured questionnaire that
included questions on smoking, drinking, and medical/
dental history as well as information on demographics
and dietary habits. Each subject received $20 reimburse-
ment for their participation time.
Smoking tobacco use was defined in terms of cigar-
ettes, pipes, and cigars. An “ever smoker” was defined as
a person who self-reported smoking at least 100 cigar-
ettes during the course of his/her lifetime or having
smoked pipes or cigars for six months or more. A “cur-
rent smoker” was defined as a person who self-reported
smoking within the calendar year prior to the year of
diagnosis while an “ex-smoker” was defined as an ever
smoker who had quit smoking for more than one calen-
dar year prior to the diagnosis year. For instance, a
subject diagnosed in 2005 who quit smoking in 2004,
would be classified as a current smoker; however, the
same individual would be classified as an ex-smoker if
s/he quit smoking in 2003. Cigarette equivalents were
calculated based on the conversion factor of 1 cigarette
= 1/2 pipe = 1/4 cigar and reported in terms of average
cigarette equivalents per day [15]. Pack-year equivalents
of smoking was calculated based upon the average num-
ber of pack-equivalents smoked per day times the num-
ber of smoking years.
Alcoholic beverage consumption was obtained in terms
of beer, wine, and hard liquor. An “ever drinker” was
defined as a person who self-reported consuming at least
12 drinks of any alcoholic beverage type over his/her life-
time. A “current drinker” was defined as a person who
reported drinking any type of alcoholic beverage within the
calendar year prior to the diagnosis year while an “ex-drin-
ker” was defined as an ever drinker who had discontinued
all drinking for more than one calendar year prior to the
diagnosis year. The average number of drinks consumed
per week was calculated based upon the reported number
of 12-ounce beers, 4-ounce glasses of wine, and 1.5-ounce
shots of hard liquor consumed per week [15-17].
We employed standard statistical methods to evaluate
differences in means and proportions. Odds ratios (ORs)
and their 95% confidence intervals (95% CIs) were
obtained using unconditional logistic regression [18].
Where indicated, ORs were adjusted for age (4 levels),
gender, education (3 levels), daily fruit & vegetable
intake (4 levels), and smoking (current vs. non-current)
or drinking (4 levels). Levels of tobacco smoking (aver-
age cigarette equivalents/day, pack-year equivalents)
were stratified into tertiles based upon consumption
levels in the benign conditions group while the fre-
quency of alcohol consumption was categorically defined
as 0, > 0-< 7, 7-20, and > 20 drinks/wk. Crude and
adjusted ORs were estimated by entering the applicable
smoking and drinking terms, as factored variables, into
the statistical models.
Tests of linear trend were conducted by adding the
relevant ordinally-defined variable as a variate into the
next lower order model and evaluating the statistical
significance of that addition using the Wald statistic. An
exploratory evaluation of the interaction between smok-
ing and drinking was performed.
The study protocol was reviewed and approved by the
Institutional Review Boards of the University of Puerto
Rico Medical Sciences Campus and New York
University.
Results
A total of 241 subjects meeting the study eligibility cri-
teria were included in the analysis. Table 1 presents the
distribution of study participants by key variables of
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benign group (n = 155) while the two groups were not
significantly different in terms of gender, education, or
fruit and vegetable intake.
Smoking
Among the 86 subjects diagnosed with an OPMD, 52.3%
reported ever smoking cigarettes while 4.7% and 2.3%
had smoked cigars or pipes, respectively. Of the 155
subjects diagnosed with a benign oral tissue condition,
the corresponding percentages were 36.1%, 2.6%, and
1.9%. None of the study subjects reported using smoke-
less tobacco.
Table 2 presents ORs for smoking associated with
having an OPMD relative to having a benign oral tissue
condition. Ever versus nevers m o k i n gw a sa s s o c i a t e d
w i t ham o r et h a nt w o - f o l di n c r e a s ei nt h eo d d so fh a v -
ing an OPMD (ORadj = 2.53, 95% CI: 1.33-4.80). When
we stratified ever smokers in terms of ex- and current
smoking, the adjusted OR was strongest for current
smokers (ORadj = 4.32, 95% CI: 1.99-9.38) and only
modestly elevated for ex-smokers (ORadj = 1.47, 95% CI:
0.67-3.21), linear test of trend, Ptrend <0 . 0 0 1 .W h e n
current and noncurrent (i.e., never & ex-) smokers were
compared, the adjusted OR for having an OPMD rela-
tive to a benign oral condition, was 3.72 (95% CI: 1.83-
7.56).
Smoking level was defined in terms of average cigar-
ette equivalents per day and pack-year equivalents. At
each level of smoking, adjusted ORs were over twice as
high for smokers relative to never smokers, and the
tests of linear trend were statistically significant.
When we simultaneously included terms for both cur-
rent smoking (current vs. noncurrent) and average cigar-
ette-equivalents/day in the adjusted model, the OR for
Table 1 Distribution of demographic variables by
diagnostic group
Variable OPMDs
a
n(%)
Benign
b
n(%)
Age
30-49 18 (20.9) 52 (33.5)
50-59 20 (23.3)) 37 (23.9)
60-69 26 (30.2) 43 (27.7)
70+ 22 (25.6) 23 (14.8)
P = 0.09
c
Mean (SD) 60.0 (12.5) 55.6 (12.3)
P = 0.009
d
Gender
Males 40 (46.5) 58 (37.4)
Females 46 (53.5) 97 (62.6)
P = 0.17
c
Education
< 12 yrs 28 (32.6) 37 (23.9)
12 yrs/High School 15 (17.4) 29 (18.7)
> 12 yrs 43 (50.0) 89 (57.4)
P = 0.34
c
Fruit & vegetable servings/day
Mean (SD) 1.14 (0.9) 1.23 (0.9)
P = 0.51
d
Total 86 155
a Oral Potentially Malignant Disorders: oral hyperkeratosis, epithelial
hyperplasia, and oral epithelial dysplasia
b Oral Benign Tissue Conditions
c Based on c
2 test
d Based on t-test
Table 2 Odds ratios for smoking associated with OPMDs
relative to oral benign tissue conditions
Exposure OPMDs
(n)
Benign
(n)
OR
a 95%
CI
ORadj
b 95%
CI
Never smokers 38 99 1.0 — 1.0 —
Ever smokers 48 56 2.23 1.31-
3.82
2.53 1.33-
4.80
Never smokers 38 99 1.0 — 1.0 —
Ex-smokers 17 30 1.48 0.73-
2.98
1.47 0.67-
3.21
Current
smokers
31 26 3.11 1.64-
5.90
4.32 1.99-
9.38
Ptrend 0.001 <
0.001
Noncurrent
smokers
55 129 1.0 — 1.0 —
Current smokers 31 26 2.8 1.52-
5.14
3.72 1.83-
7.56
Average cigarette equivalents/day
0 38 99 1.0 — 1.0 —
> 0-< 20 26 27 2.51 1.30-
4.83
2.83 1.35-
5.93
20+ 22 29 1.98 1.01-
3.86
2.21 1.02-
4.80
Ptrend 0.02 0.03
Pack-year equivalents of smoking
0 38 99 1.0 — 1.0 —
> 0-< 15.5 21 29 1.89 0.96-
3.70
2.26 1.06-
4.83
15.5+ 27 27 2.61 1.36-
5.00
2.83 1.32-
6.06
Ptrend 0.003 0.006
Age started smoking (Ever smokers only)
18+ 27 30 1.0 — 1.0 —
< 18 21 26 0.9 0.41-
1.95
0.81 0.35-
1.91
a Crude OR
b OR adjusted for age (four levels), gender, education (three levels), fruit &
vegetable intake (four levels), and drinking (four levels)
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1.28-7.03) while ORs for each smoking level were atte-
nuated (i.e., adjusted ORs for average cigarette-equiva-
lents/day declined from 1.0, 2.83, 2.21 (Table 2) to 1.0,
1.68, 1.23, Ptrend = 0.70). When we conducted an analo-
gous analysis that added current smoking and pack-year
equivalents of smoking to the adjusted model, the OR
for current smoking was 2.95 (95% CI: 1.24-7.03), and
the ORs for pack-year equivalents of smoking declined
from 1.0, 2.26, 2.83 (Table 2) to 1.0, 1.48, 1.45 (Ptrend =
0.44).
Among ever smokers, the age at which smoking began
did not differ significantly between the OPMD and
benign conditions groups (OR = 0.81, 95% CI: 0.35-
1.91).
Drinking
Table 3 presents ORs for drinking in relation to having
an OPMD relative to having a benign oral tissue condi-
tion. No adjusted ORs approached statistical signifi-
cance, and few point estimates exceeded 1.0, whether
consumption was defined in terms of ever, current, level
(drinks/week), or beverage type.
When we compared the mean number of alcoholic
drinks consumed per week for ever drinkers, persons in
the OPMD group had a higher mean total consumption
compared to the benign conditions group but the differ-
ence did not approach statistical significance (18.8 vs.
16.2 drinks/wk, P = 0.68). On the other hand, among
heavy drinkers (> 20 drinks/wk), the OPMD group con-
sumed, on average, fewer drinks/wk than the benign
conditions group (55.1 vs. 70.3 drinks/wk), but the dif-
ference was not statistically significant (P =0 . 4 6 ) .A f t e r
stratifying on type of alcoholic beverage, consumption
was marginally higher in the OPMD group (beer: 9.4 vs.
8.1; wine: 1.1 vs. 0.8; hard liquor: 8.3 vs. 7.4); but again,
not statistically significant.
Smoking & Drinking Interaction
When we fitted an interaction term for current smoking
(yes/no) and alcohol consumption (< 7, 7+drinks/week)
to the adjusted model (referent category: never/ex-smo-
kers and < 7 drinks/week), adjusted OR point estimates
were 2.5 or higher for current smokers who drank either
< 7 or 7+ drinks/week. For noncurrent smokers who
drank 7+ drinks/week, the ORadj was 0.7 (Table 4).
Additional Analyses
Point estimates for smoking and drinking did not
change notably when we added variables for denture use
and body mass index (BMI) to the adjusted model. In
addition, adding lichen planus cases to the OPMD
group had little impact on the adjusted ORs reported in
Tables 2, 3 and 4. The adjusted ORs were also similar
when age was entered into the model as a continuous,
rather than categorical, variable.
Discussion
Tobacco and alcohol consumption are well-recognized
risk factors for cancers of the oral cavity and pharynx
[12,17,19]. In Puerto Rico, it is estimated that 76% of
oral and pharyngeal cancer cases among men and 52%
among women are attributable to smoking and/or alco-
hol consumption [17]. Comparatively few epidemiologic
studies, however, have investigated the role of tobacco
and alcohol in relation to OPMD risk. In the current
study, conducted in Puerto Rico, we evaluated smoking
and drinking as risk factors for OPMDs.
Smoking
The favored form of tobacco use can vary across geo-
graphic areas and cultures around the world. In the Uni-
ted States, Europe, Australia, and Japan, cigarettes,
cigars, and pipes are the major types of smoking
tobacco, while chewing tobacco and snuff are the most
common forms of smokeless tobacco [20]. Although the
prevalence of tobacco smoking is high in India, Pakistan,
China, and other areas of Asia, smokeless tobacco, used
either alone or as part of a concoction and in forms
including betel quid, bidis, paan, naswar, or nass, is also
popular [20-23].
In our study, conducted in Puerto Rico, persons
smoked tobacco primarily in the form of cigarettes, with
few subjects in either the OPMD or benign conditions
group claiming to smoke cigars or pipes. Although smo-
keless tobacco use has been implicated as a risk factor
for both oral leukoplakia and oral cancer on the United
States mainland [24-26], in our study, no subjects with
an OPMD or a benign tissue condition reported using
smokeless tobacco.
In the present study and after adjusting for drinking
and other potentially confounding factors, current
smoking was strongly associated with OPMD risk.
There was a more than four-fold increased risk among
current versus never smokers; however, the risk was
notably attenuated among former smokers. These find-
ings are consistent with numerous previous studies of
oral leukoplakia [21,27-32], OED [15,33], erythroplakia
[34], and oral cancer [16,17,35]. Our finding of a sub-
stantially decreased OPMD risk for former smokers rela-
tive to current smokers underscores the public health
benefit associated with smoking cessation.
Previous studies have reported dose- and/or duration-
response relationships between smoking and the risk of
oral leukoplakia, erythroplakia, and OED
[15,21,34,36,37]. In the current investigation, the risk of
having an OPMD increased in a monotonic fashion with
increasing pack-year equivalents of smoking. The linear
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equivalents smoked per day was also statistically signifi-
cant, but did not increase in a stepwise fashion, perhaps
due to the relatively small OPMD sample size. Of note,
our findings suggest that current smoking status is a
stronger risk factor for OPMDs than reported level of
smoking.
Drinking
Alcohol consumption is an established risk factor for
oral cancer [12,16,17,35]. Nevertheless, findings from
investigations into the association between alcohol con-
sumption and either oral leukoplakia or other potentially
premalignant oral diagnoses have not been consistent
across studies. In the current investigation, we found lit-
tle evidence that overall alcohol consumption is asso-
ciated with increased OPMD risk. Our results are in
keeping with several earlier studies reporting inverse or
null findings for total alcohol consumption
[21,28,29,38,39]; but not with others that reported a
positive association for either leukoplakia in general,
erythroplakia, or OED [15,34,40,41].
Table 3 Odds ratios for drinking associated with OPMDs relative to oral benign tissue conditions
Exposure OPMDs (n) Benign (n) OR
a 95% CI ORadj
b 95% CI
Never drinkers 41 73 1.0 - 1.0 —
Ever drinkers 45 82 0.98 0.58-1.66 0.63 0.33-1.21
Never drinkers 41 73 1.0 - 1.0 —
Ex-drinkers 14 22 1.13 0.52-2.45 0.63 0.25-1.57
Current drinkers 31 60 0.92 0.52-1.64 0.63 0.32-1.26
Ptrend 0.79 0.20
Drinks/week, all alcohol combined
c
0 41 73 1.0 - 1.0 —
> 0-< 7 22 44 0.89 0.47-1.69 0.66 0.32-1.37
7-20 10 22 0.81 0.35-1.87 0.39 0.14-1.13
> 20 12 13 1.64 0.69-3.93 0.78 0.27-2.26
Ptrend 0.55 0.32
Mean drinks/wk (all types combined)
> 0 18.8 (29.9
d) 16.2 (33.8) P = 0.68
e
> 20 55.1 (38.0) 70.3 (58.9) P = 0.46
e
Type of alcoholic beverages
c
Beer, drinks/wk
< 7 72 133 1.0 - 1.0 —
7+ 14 22 1.18 0.57-2.44 0.66 0.27-1.61
Mean 12 oz beers/wk
9.4 (16.8) 8.1 (17.0) P = 0.66
e
Wine, drinks/wk
< 7 83 152 1.0 - 1.0 —
7+ 3 3 1.83 0.36-9.28 1.74 0.30-10.11
Mean drinks of wine/wk
1.1 (2.6) 0.8(1.7) P = 0.44
e
Hard Liquor, drinks/wk
< 7 76 140 1.0 - 1.0 —
7+ 10 15 1.23 0.53-2.87 0.62 0.23-1.65
Mean drinks of hard liquor/wk
8.3(22.4) 7.4(23.3) P = 0.84
e
a Crude OR
b OR adjusted for age (four levels), gender, education (three levels), fruit & vegetable intake (four levels), and current smoking
c One OPMD and three benign condition subjects did not report level of drinking
d Standard deviation
e Based on t-test
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found that risks associated with drinking are dependent
upon the level of alcohol intake, with the highest risks
observed for the highest level of alcohol intake
[15,34,41]. After adjusting for various potential confoun-
ders; however, we found no evidence of an increased
OMPD risk even among those persons who consumed >
20 drinks/wk.
Previous studies have reported that the risk of oral
cancer and OPMDs can vary by beverage type, i.e., beer,
wine, and hard liquor [15,16,39,42-44]. In Puerto Rico,
the consumption of hard liquor, particularly when used
without a mixer, has been associated with a much stron-
g e rr i s ko fo r a lc a n c e rt h a nb e e ro rw i n e[ 4 4 ] .I no u r
analysis of OPMD risk, however, we found little evi-
dence that any type of alcoholic beverage consumption
was associated with an increased OPMD risk in Puerto
Rico.
Smoking and Drinking Interaction
Previous studies have reported evidence of a more than
additive effect of both smoking and drinking on the risk
of oral cancer and OED [12,15-17]. Our exploratory
analyses revealed no evidence that alcohol consumption
modified the effect of smoking in terms of OPMD risk,
although this finding is based on a relatively small sam-
ple that hindered an in-depth examination of the poten-
tial interaction.
Limitations
When interpreting our findings, it is important to con-
sider study limitations. The relatively small sample size
reflects a comparatively low rate of OPMD diagnosis in
Puerto Rico [45] and limited our ability to conduct sub-
group analyses related to smoking, drinking, and their
interaction.
We utilized a comparison group comprised of persons
diagnosed with a benign oral soft tissue condition rather
than a traditional “disease-free” group. The strategy
used provides an estimate of exposure patterns among
persons diagnosed with asymptomatic oral lesions in
Puerto Rico. It is possible, however, that one or another
oral condition included in our benign conditions group
is positively associated with either smoking or alcohol
consumption; in that instance, the prevalence of smok-
ing and drinking in our comparison group may exceed
that of the background PR source population. Had we
used a “disease-free” comparison group, ORs for smok-
ing may have been higher than our current estimates,
and ORs for drinking may have been closer to or
exceeded the null value, 1.0.
Adjustment was made for a number of potential con-
founders, and further adjustment for denture use and
BMI had little impact on the reported ORs; however,
our results may reflect some uncontrolled confounding.
All exposures were measured based upon subject self-
reports, and some degree of exposure misclassification
may have occurred. In addition, since many OPMDs
and benign oral tissue conditions are asymptomatic and
may not be biopsied, we cannot rule out the possibility
that undiagnosed cases are different from subjects
included in the study in terms of the risk factors of
interest.
Conclusion
We compared smoking and drinking patterns between
individuals diagnosed with an oral potentially malignant
disorder relative to persons diagnosed with a benign
oral tissue condition. Our findings suggest that current
smoking is a substantial risk factor for OPMDs while
former smokers have a considerably reduced risk com-
pared to current smokers. There was little evidence sug-
gesting that alcohol consumption was positively
associated with OPMD risk in Puerto Rico.
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